P., T., P., S., N., A., X., W., G., L., X., L., . . . N., C. (2017). Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.

P., Tanajak, Sa-nguanmoo P., Apaijai N., Wang X., Liang G., Li X., Jiang C., Chattipakorn S., and Chattipakorn N. Comparisons of Cardioprotective Efficacy between Fibroblast Growth Factor 21 and Dipeptidyl Peptidase-4 Inhibitor in Prediabetic Rats. 2017.

P., Tanajak, et al. Comparisons of Cardioprotective Efficacy between Fibroblast Growth Factor 21 and Dipeptidyl Peptidase-4 Inhibitor in Prediabetic Rats. 2017.